Why the study?
Existing surgical risk assessment systems have generally not been verified for patients with gynecologic cancer.
Does a proposed surgical risk assessment scoring model predict postoperative complications in gynecological oncologic patients?
Does a proposed surgical risk assessment scoring model predict postoperative complications in gynecological oncologic patients?
A simple scoring model incorporating metoprolol use and upper abdominal surgery can predict postoperative complications in gynecological cancer patients.
Metoprolol use and upper abdominal surgery may refine risk models in gynecologic cancer surgery; leaves open need for prospective validation before clinical adoption.
No takes yet. Share an insight, caveat, or question.
Biçer et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: